🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Catherine K. Luo

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-2646-9566
Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell–Mediated Immunotherapies”.

The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell–Mediated Immunotherapies

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0430
N/A
0DataRank · unranked
166 citations

Snigdha Pramanik, Leila J. Williams, Hannah R. Hodges, Courtney W. Hudgens, Grant M. Fischer +11 more

Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis

Cell Death and Disease(2021)10.1038/s41419-021-03473-6
N/A
0DataRank · unranked
17 citations

Dan Wang, Yongde Luo, Liang‐Hao Hu, Ya‐Wei Bi, Jun‐Tao Ji +12 more

Eliminating fibroblast activation protein-α expressing cells by photoimmunotheranostics

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.18.469110
N/A
0DataRank · unranked
1 citations

James D. Barnett, Balaji Krishnamachary, Yelena Mironchik, Catherine K. Luo, Hisataka Kobayashi +2 more

Evaluating near‐infrared photoimmunotherapy for targeting fibroblast activation protein‐α expressing cells in vitro and in vivo

Cancer Science(2022)10.1111/cas.15601
N/A
0DataRank · unranked
14 citations

James D. Barnett, Balaji Krishnamachary, Yelena Mironchik, Catherine K. Luo, Hisataka Kobayashi +2 more

IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer

npj Precision Oncology(2025)10.1038/s41698-025-01041-1
N/A
0DataRank · unranked
14 citations

Tuyen Bui, Juliana Navarro-Yepes, Sanaz Ghotbaldini, Bethanie Quintela, Catherine K. Luo +19 more